To verify the diagnosis of homozygous MTAP deletion and contrast this status with the extensive MTAP expression levels in non-malignant tissue, we performed immunohistochemistry on intracranial xenografted gliomas in mice. This evidence concerns the gene MTAP and central nervous system cancer.